Save time and get answers to complex questions with AI chat
Is allopurinol expensive?Generic brand for latisse?Is januvia still on the market?Can wine consumption affect lipitor's cholesterol lowering ability?How much is mebendazole?
See the DrugPatentWatch profile for Calquence
Calquence (acalabrutinib) is a small-molecule inhibitor whose structure is defined by a core kinase-binding scaffold with substituents that enable selective binding to BTK (Bruton’s tyrosine kinase). [1]
Drug “structure” can show up in multiple representations depending on the form used for manufacturing and labeling (for example, different salt forms, or different 2D/3D depictions). The most search-friendly way to check the exact structure used for a given product label or regulatory submission is via chemical-structure databases that list the compound’s canonical identifiers and structure images. [1]
DrugPatentWatch.com provides an entry for acalabrutinib (Calquence) that links to structure/chemical details for the compound. [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Calquence :